POST Online Media Lite Edition


Teva Pharma to buy Allergan's Anda distribution for half a billion

Staff Writer |
Allergan has entered into a definitive agreement under which Teva Pharmaceutical Industries will acquire its Anda distribution business for $500 million.

Article continues below

Anda distributes generic, brand, specialty and Over-the-Counter pharmaceutical products from more than 300 manufacturers to retail independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics and physician offices across the United States.

Until the transaction is completed, Allergan will continue to operate Anda in a business-as-usual mode, provide full support to manage the business, introduce new products and maximize its partnerships with customers.

Beginning with its second quarter 2016 earnings report, Allergan will report its Anda business as discontinued operations.

For the second quarter of 2016, Anda is expected to contribute approximately $375 million in net revenues excluding sales of Allergan's branded products and approximately $0.05 in earnings per share (EPS).

For the full year 2016, Anda is expected to contribute approximately $1.5 billion in third-party net revenue and approximately $0.15 in EPS.

What to read next

Dr. Reddy’s to buy product portfolio from TEVA for U.S. for $350m
Teva withdraws from Mylan, will buy Allergan Generics in $40.5 billion transaction
Teva Pharma completes Actavis Generics acquisition